Key result
A 68-year-old woman with SARS-CoV-2 infection developed mild encephalopathy with a reversible splenial lesion that improved clinically and radiographically over five weeks.
Why the study?
Mild encephalitis/encephalopathy with reversible splenial lesions is a rare viral-associated syndrome typically reported in children, prompting this report of an adult presentation associated with SARS-CoV-2 infection.
Case Report (n=1)
SARS-CoV-2 infection can be associated with mild encephalopathy with a reversible splenial lesion (MERS), which may take weeks to resolve radiographically and clinically.
May aid MERS recognition in COVID-19 encephalopathy; single case leaves open incidence and management questions.
Viral-associated encephalitis/encephalopathy includes a wide spectrum of syndromes reported often in children. A rare form presents with mild encephalitis/encephalopathy and reversible splenial lesion(s). This report describes a case of this rare presentation associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a 68-year-old woman. The patient presented to the hospital with altered mental status. Examination revealed mild encephalopathy with disorientation to date and time. Initial laboratory workup was significant for mild hypernatremia and acute kidney injury, and a polymerase chain reaction (PCR) test for SARS-CoV-2 was positive. MRI of the brain revealed an area of hyperintensity and water restriction in the corpus callosum. The patient was treated with tocilizumab, dexamethasone, and remdesivir. MRI of the brain five weeks later revealed partial resolution of the hyperintensity, and complete resolution of the restricted diffusion previously seen in the corpus callosum, which confirmed the diagnosis of mild encephalitis/encephalopathy with a reversible splenial lesion. We highlight the importance of recognizing this phenomenon in association with SARS-CoV-2 infection.
No takes yet. Share an insight, caveat, or question.
Reyes et al. (2023) conducted a case report in Mild encephalopathy with reversible splenium lesion (MERS) associated with SARS-CoV-2 infection (n=1). SARS-CoV-2 infection was evaluated. A 68-year-old woman with SARS-CoV-2 infection developed mild encephalopathy with a reversible splenial lesion that improved clinically and radiographically over five weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: